Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors
Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts.
Credit available for this activity expires: 3/29/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000542?ecd=bdc_podcast_libsyn_mscpedu
Create your
podcast in
minutes
It is Free